Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences
Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced the addition of Dr. Mahavir Prashad, an acknowledged scientific leader and industry veteran, to its scientific leadership team as Vice President of Early Phase Process Development.
Sai Life Sciences, one of India’s fastest growing Contract Research,
Development & Manufacturing Organizations (CRDMOs), today announced
the addition of Dr. Mahavir Prashad, an acknowledged scientific leader
and industry veteran, to its scientific leadership team as Vice
President of Early Phase Process Development. With over three decades of
experience in advanced research and roles of increasing responsibility
in one of the world’s leading pharmaceutical companies, Dr. Prashad will
provide impetus to Sai Life Sciences’ growing capabilities and help
accelerate the drug development programmes of its customers.
Making the announcement, CEO & Managing Director of Sai Life
Sciences, Krishna Kanumuri said, “We see Early Phase Process Development
as a key pivot in compressing the time to market of our clients’ drug
development programs. This priority has now received significant
momentum with the joining of Dr. Mahavir Prashad. His deep scientific
expertise and rich experience of managing outsourced drug development
programs will no doubt be a valuable addition as we strive to build a
world class delivery engine.”
Dr. Prashad is a recognized leader in Chemical Process R&D and
leveraging Green Chemistry principles and modern technologies in API
synthesis. He possesses an excellent scientific track record through 94
publications, 4 review articles, 1 book chapter, 71 patent/applications,
and 10 invited lectures at scientific conferences. He was awarded
Novartis Leading Scientist award in 2002 and also the 2010 Diversity
& Inclusion award of the Novartis Pharmaceuticals Corporation. Dr.
Prashad has a Ph.D. in Organic Chemistry from the Central Drug Research
Institute in Lucknow India and was awarded a Post-Doctoral Research
Fellowship at Duke University in North Carolina, USA.
Commenting on his appointment, Dr. Mahavir Prashad said, “I am very
excited to be joining Sai Life Sciences and its passionate leadership
team with a clear Early Phase Development acceleration strategy. I am
looking forward to working with talented and dedicated Scientists at Sai
who are enabling their partners in delivering novel medicines to
patients in a speedy and socially responsible manner through Science and
Innovation.”
Sai Life Sciences is currently amid an organization-wide
transformation. It is investing US$150 million during 2019-23, as part
of the Sai Nxt
initiative, across three core areas – people & culture, processes
& automation, infrastructure & scientific capabilities.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance